心理治疗与酒精使用障碍患者发生酒精相关性肝病风险降低相关
本研究为回顾性队列研究,纳入Mass General Brigham生物样本库中9635例酒精使用障碍患者,随访自诊断起平均9.2年。心理治疗与酒精相关性肝病发生风险降低相关(HR 0.59,95%CI 0.50-0.71,P<.001),个体和团体心理治疗均显示关联,肝硬化患者中心理治疗与肝失代偿率降低相关(HR 0.68,95%CI 0.48-0.95,P=.03)。作者认为临床医生应考虑使用心理治疗来预防酒精相关性肝病的发展。
要点
- 心理治疗与酒精使用障碍患者酒精相关性肝病发生风险降低相关(HR 0.59,95%CI 0.50-0.71,P<.001)。
- 个体心理治疗(HR 0.70,95%CI 0.56-0.86,P<.001)和团体心理治疗(HR 0.76,95%CI 0.61-0.94,P=.01)均与风险降低相关。
- 肝硬化患者中心理治疗与肝失代偿率降低相关(HR 0.68,95%CI 0.48-0.95,P=.03)。
核心结论
- 在酒精使用障碍背景下接受心理治疗与酒精相关性肝病发生率和进展风险降低相关。
- 鉴于心理治疗的安全性和潜在获益,临床医生应考虑使用心理治疗来预防酒精相关性肝病的发展。
研究设计与样本
- 回顾性队列研究,使用国际疾病分类第9版和第10版编码在Mass General Brigham生物样本库中识别9635例酒精使用障碍患者。
- 自酒精使用障碍诊断起平均随访9.2年,使用Cox回归模型生成酒精相关性肝病发生风险的风险比(HR),并调整包括接受药物辅助治疗在内的多种其他影响因素。
主要发现
- 队列中60.4%为男性,83.5%为白人,中位年龄57.0岁,3544例(36.8%)接受了心理治疗。
- 1135例(11.8%)发生了酒精相关性肝病。
- 多变量分析中心理治疗与酒精相关性肝病发生率降低相关(HR 0.59,95%CI 0.50-0.71,P<.001)。
- 个体心理治疗与酒精相关性肝病风险降低相关(HR 0.70,95%CI 0.56-0.86,P<.001),团体心理治疗也与风险降低相关(HR 0.76,95%CI 0.61-0.94,P=.01)。
- 肝硬化患者中心理治疗与肝失代偿率降低相关(HR 0.68,95%CI 0.48-0.95,P=.03)。
临床怎么用
- 作者认为,鉴于心理治疗的安全性和潜在获益,临床医生应考虑使用心理治疗来预防酒精使用障碍患者发生酒精相关性肝病。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Alcohol-associated liver disease (ALD) is a devastating complication of alcohol use disorder (AUD). Once it develops, ALD is exceedingly difficult to treat; it therefore is critical to identify ways to prevent ALD. By treating the causes of increased alcohol consumption, psychotherapy may offer prophylactic benefit against the development of ALD for patients with AUD. METHODS: In this retrospective cohort study, we used International Classification of Diseases, 9th and 10th revision, codes to identify 9635 patients with AUD in the Mass General Brigham Biobank. The mean follow-up period from AUD diagnosis was 9.2 years. We used Cox regression models to generate hazard ratios (HR) for the development of ALD given the receipt or nonreceipt of psychotherapy, adjusting for a range of other contributors including the receipt of medication-assisted treatment. RESULTS: In our cohort, 60.4% of patients were men, 83.5% of patients were white, the median age was 57.0 years, and 3544 patients (36.8%) received psychotherapy. ALD developed in 1135 patients (11.8%). In multivariable analysis, psychotherapy was associated with a reduced rate of ALD (HR, 0.59; 95% CI, 0.50-0.71; P < .001). This association held for both individual psychotherapy (HR, 0.70; 95% CI, 0.56-0.86; P < .001) and group psychotherapy (HR, 0.76; 95% CI, 0.61-0.94; P = .01). Among patients with cirrhosis, psychotherapy was associated with a lower rate of hepatic decompensation (HR, 0.68; 95% CI, 0.48-0.95; P = .03). CONCLUSIONS: The receipt of psychotherapy in the setting of AUD is associated with reduced incidence and progression of ALD. Given the safety and potential benefit of psychotherapy, clinicians should consider using it to prevent the development of ALD.
引用
- Vannier AGL, Przybyszewski EM, Shay J, et al. Psychotherapy for Alcohol Use Disorder Is Associated With Reduced Risk of Incident Alcohol-Associated Liver Disease. Clin Gastroenterol Hepatol. 2022. PMID: 35964893. doi:10.1016/j.cgh.2022.08.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。